Online Media Kit
FEATURED STORY
March 06, 2018 | POZ
Vaginal Ring Appears to Cut Women's HIV Rate in Half in New Study
The open-label follow-up to a previous placebo-controlled study of an HIV-preventing ring is seeing high use among women. More »
FEATURED STORY
December 19, 2017 | BBC World Hacks
The Ring That Could Help Save Women's Lives (AUDIO)
A new form of protection being tested in Malawi could be a real game-changer. World Hacks meets the women pioneering this approach and taking control of their own protection. More »
FEATURED STORY
May 04, 2017 | Economist (UK)
How to protect women against both HIV and pregnancy
A newly-developed vaginal ring releases small doses of drugs over a three-month period More »
FEATURED STORY
February 26, 2016 | The New York Times editorial
Helping Women in Africa Avoid H.I.V.
Now, women in the developing world have new hope. The results of two major studies in Africa that were released Monday show that a new device could help protect women against H.I.V. More »
Media Highlights
July 24, 2019 | Medical Daily
This Vaginal Ring Promises To Help Women Prevent HIV
Researchers said the preventive tool was created to be discreet, long-acting method for women. More »
July 23, 2019 | POZ
Vaginal Ring Shows Promise as HIV Prevention Tool Women Will Use
The monthly vaginal ring appeared to lower the risk of HIV by about 39% overall in a recent study. More »
July 19, 2019 | Bhekisisa (South Africa)
What if protecting yourself from HIV was as easy as using a tampon?
A vaginal ring inserted monthly could reduce women’s risk of contracting HIV by 63%, according to a recent study. More »
June 21, 2019 | Avert
Vaginal ring can substantially impact HIV prevention, reveals mathematical model
A mathematical modelling study suggests that the dapivirine vaginal ring could substantially reduce HIV infections among South African women and be an affordable intervention depending on roll-out... More »
June 20, 2019 | Chemical Watch
Commission adopts REACH authorisation decisions
The European Commission announced REACH authorization decisions on several substances, including dapivirine. More »